Skip to main content

Research Repository

Advanced Search

Use of mirtazapine in patients with chronic breathlessness: a case series

Lovell, Natasha; Bajwah, Sabrina; Maddocks, Matthew; Wilcock, Andrew; Higginson, Irene J.

Authors

Natasha Lovell

Sabrina Bajwah

Matthew Maddocks

Andrew Wilcock

Irene J. Higginson



Abstract

Background: Breathlessness remains a common and distressing symptom in people with advanced disease with few effective
treatment options. Repurposing of existing medicines has been effective in other areas of palliative care, for example, antidepressants
to treat pain, and offers an opportunity to deliver improved symptom control in a timely manner. Previous case series have shown
reduced breathlessness following the use of sertraline (a selective serotonin reuptake inhibitor) in people with chronic obstructive
pulmonary disease.
Cases: Six cases where mirtazapine, a noradrenergic and specific serotonergic antidepressant, was used to treat chronic breathlessness
in advanced lung disease.
Case management: All cases received mirtazapine at a starting dose of 15 mg, prescribed under the care of their primary care
physician. Cases had been receiving mirtazapine for a variable time period (2 weeks to 5 months) at the time of the interviews.
Case outcome: All cases reported less breathlessness and being able to do more. They described feeling more in control of their
breathing, and being able to recover more quickly from episodes of breathlessness. Some cases also reported beneficial effects on
anxiety, panic, appetite and sleep. No adverse effects were reported.
Discussion: Patients with chronic breathlessness in this case series reported benefits during mirtazapine treatment. To determine the
effectiveness of mirtazapine in alleviating breathlessness and improving quality of life in chronic lung disease, blinded randomised
trials are warranted.

Citation

Lovell, N., Bajwah, S., Maddocks, M., Wilcock, A., & Higginson, I. J. (2018). Use of mirtazapine in patients with chronic breathlessness: a case series. Palliative Medicine, doi:10.1177/0269216318787450. ISSN 1477-030X

Journal Article Type Article
Acceptance Date Jun 20, 2018
Online Publication Date Jul 20, 2018
Publication Date Jul 20, 2018
Deposit Date Sep 10, 2018
Publicly Available Date Sep 10, 2018
Journal Palliative Medicine
Electronic ISSN 1477-030X
Publisher SAGE Publications
Peer Reviewed Peer Reviewed
DOI https://doi.org/10.1177/0269216318787450
Keywords Breathlessness, shortness of breath, mirtazapine, antidepressant, case series, advanced disease

Files




Downloadable Citations